These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8408733)

  • 41. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension.
    Saseen JJ; Carter BL; Brown TE; Elliott WJ; Black HR
    Hypertension; 1996 Jul; 28(1):109-14. PubMed ID: 8675249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of nifedipine on serum digoxin concentration and renal digoxin clearance.
    Schwartz JB; Migliore PJ
    Clin Pharmacol Ther; 1984 Jul; 36(1):19-24. PubMed ID: 6734045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of rifampicin on the pharmacokinetics and pharmacodynamics of orally administered nilvadipine to healthy subjects.
    Saima S; Furuie K; Yoshimoto H; Fukuda J; Hayashi T; Echizen H
    Br J Clin Pharmacol; 2002 Feb; 53(2):203-6. PubMed ID: 11851646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonlinear pharmacokinetics of oral quinidine and verapamil in healthy subjects: a clinical microdosing study.
    Maeda K; Takano J; Ikeda Y; Fujita T; Oyama Y; Nozawa K; Kumagai Y; Sugiyama Y
    Clin Pharmacol Ther; 2011 Aug; 90(2):263-70. PubMed ID: 21716273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and pharmacodynamics of nifedipine in patients at steady state.
    Gutierrez LM; Lesko LJ; Whipps R; Carliner N; Fisher M
    J Clin Pharmacol; 1986; 26(8):587-92. PubMed ID: 3793948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
    Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic interaction between nifedipine and propranolol.
    Zylber-Katz E; Turetz-Abramovitch M; Koren G; Levy M
    Fundam Clin Pharmacol; 1988; 2(1):29-35. PubMed ID: 3371839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
    Grundy JS; Foster RT
    Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absence of a pharmacokinetic interaction between quinidine and diazepam.
    Rao BR; Rambhau D
    Drug Metabol Drug Interact; 1995; 12(1):45-51. PubMed ID: 7555001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of nifedipine metabolism in dogs by erythromycin: difference between the gut wall and the liver.
    Tsuruta S; Nakamura K; Arimori K; Nakano M
    J Pharm Pharmacol; 1997 Dec; 49(12):1205-10. PubMed ID: 9466344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
    Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
    Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
    Czendlik CH; Sioufi A; Preiswerk G; Howald H
    Eur J Clin Pharmacol; 1997; 52(6):451-9. PubMed ID: 9342580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine.
    Hardy BG; Zador IT; Golden L; Lalka D; Schentag JJ
    Am J Cardiol; 1983 Jul; 52(1):172-5. PubMed ID: 6858908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
    Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pharmacodynamics and pharmacokinetics of the combination of nifedipine and doxazosin.
    Donnelly R; Elliott HL; Meredith PA; Howie CA; Reid JL
    Eur J Clin Pharmacol; 1993; 44(3):279-82. PubMed ID: 8491245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nifedipine pharmacokinetics and pharmacodynamics during the immediate postpartum period in patients with preeclampsia.
    Barton JR; Prevost RR; Wilson DA; Whybrew WD; Sibai BM
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):951-4. PubMed ID: 1951561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Separate and combined effects of nadolol and nifedipine on the cardiac response to exercise.
    Wilkins MR; Woods KL; Jack DB; Kendall MJ; Laugher SJ
    Eur J Clin Pharmacol; 1985; 28(2):113-7. PubMed ID: 3987793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose-dependence of the nifedipine-digoxin interaction?
    Kirch W; Hutt HJ; Dylewicz P; Gräf KJ; Ohnhaus EE
    Clin Pharmacol Ther; 1986 Jan; 39(1):35-9. PubMed ID: 3943268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.